Efficacy and safety of the non-steroidal anti-inflammatory drug etoricoxib in the treatment of acute ankle sprain in sports: A randomized double-blind comparative study among 2 treatments in the acute phase

Trial Profile

Efficacy and safety of the non-steroidal anti-inflammatory drug etoricoxib in the treatment of acute ankle sprain in sports: A randomized double-blind comparative study among 2 treatments in the acute phase

Not yet recruiting
Phase of Trial: Phase IV

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Etoricoxib (Primary)
  • Indications Musculoskeletal pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Oct 2008 Planned end date changed from May 2008 to Sep 2009 as reported by ClinicalTrials.gov.
    • 20 Oct 2008 Planned initiation date changed from Dec 2007 to Dec 2008 as reported by ClinicalTrials.gov.
    • 13 Sep 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top